From full-body scans to statins, Vail Health says the smartest longevity move may be simpler and cheaper than many patients expect.
The future of medicine and longevity is arriving in pieces. A wearable patch here, a whole-body scan there, a blood test promising early answers, a supplement ad insisting you are already behind. For patients, it can feel less like progress and more like static.
That tension is at the center of a recent event by Vail Health, a Colorado-based nonprofit, community-governed healthcare system, on the future of medical prevention, in which clinicians from across the health system offered something increasingly rare in the longevity conversation: restraint.
At a time when “living longer” is often packaged as a shopping list of tests, gadgets and premium services, Vail Health made a different argument – that the most meaningful gains in longevity still come from prevention, and that prevention begins long before the fancy tools.
It is a notable message, particularly as health systems, startups and concierge providers all try to define their place in the expanding longevity economy. The novelty here is not that Vail Health has access to advanced diagnostics. It is that its clinicians are publicly saying the basics still come first, and that more data is only useful if it changes what patients actually do.
Before the scans, there is the hard stuff. Chris Lindley, executive director of Vail Health Behavioral Health, distilled the point in a way that cut through the trends [1].
“Think about the healthiest 80-year-old you know,” Lindley said. “They exercise, they sleep, they probably lift weights, they have some type of purpose, they have friends, community and they play.”
Lindley urged the audience to focus on the habits that tend to get crowded out by more glamorous interventions: strength training, adequate protein intake, consistent sleep, meaningful relationships and a sense of purpose. It’s a market where “optimization” is often sold as a product, and this framing was almost anti-consumerist.
“Don’t waste your money going and spending it on supplements or tests or any other influencer thing if you’re not doing the hard things,” Lindley said.
That line lands because it quietly exposes one of longevity’s biggest contradictions: the most effective interventions are often the least profitable to sell. You cannot brand your way out of poor sleep, isolation or physical inactivity. And yet those are still among the most decisive drivers of how well people age.
The message is refreshingly direct: if your foundation is shaky, expensive add-ons will not fix the house.
Advanced tests can help, but they are not magic. That does not mean Vail Health is rejecting newer tools. If anything, the system appears to be trying to place them in a more mature framework.
Dr Melissa O’Meara, medical director of Vail Health’s concierge medicine program, said annual primary care visits remain essential, especially for routine cancer screenings such as mammograms, pap smears, PSA tests, lung cancer screening and colon cancer screening. For patients in high-elevation mountain communities, she also flagged annual skin cancer screening.
From there, O’Meara outlined the newer technologies increasingly entering the longevity mainstream: continuous glucose monitors, Prenuvo full-body scans, liquid biopsies and genome testing.
O’Meara offered an important caveat, explaining that while she wasn’t suggesting the practice was for everyone, it was something individuals should consider to determine if it was right for them. That may be the most responsible thing anyone can say in modern longevity medicine.
A continuous glucose monitor, for example, is essentially a wearable patch that shows how your blood sugar levels rise and fall throughout the day. For someone without diabetes, it is not necessarily a medical necessity, but it can be a useful mirror. If your numbers spike after lunch and a short walk helps smooth them out, that is actionable feedback.
The Prenuvo scan, a full-body MRI completed in about 45 minutes, is more complicated. Think of it like using a flashlight so powerful that it also illuminates dust you were never worried about. These scans can surface important findings, but they can also uncover harmless abnormalities that trigger a cascade of extra imaging, biopsies and anxiety.
O’Meara put it plainly, “The issue with full body MRIs is they always find something.” That is a critical point in longevity care, where the line between early detection and over-testing can be thin. More information is not automatically better information. Sometimes it is just more noise.
The promise (and limits) of early detection
Liquid biopsies, meanwhile, are blood tests designed to look for fragments of cancer DNA circulating in the bloodstream. It is an exciting idea because it sounds almost futuristic: find cancer from a vial of blood before symptoms appear.
But O’Meara’s explanation kept expectations in check. These tests are better at detecting stage II cancers and above, which means they are not yet the all-seeing early warning system the marketing may imply.
Genome testing is the area she appears to be watching most closely. “One day in my practice lifetime, it will be a universal screening,” O’Meara said. That is a bold statement, and one worth taking seriously. If genetics can eventually identify high-impact risks early enough for meaningful intervention, it could reshape preventive care. But for now, the technology still has blind spots, including the possibility of “positive” results that do not translate neatly into real disease.
This is where it becomes more interesting from a longevity perspective: the field is moving fast, but Vail Health’s clinicians are essentially arguing for humility. Use the tools, yes, but do not confuse potential with proof.
Why the heart still anchors the longevity conversation
If the longevity industry often gravitates toward the futuristic, cardiology remains a reminder that some of the most important work is deeply unglamorous.
Dr Kate Schuetze, an interventional cardiologist, framed cardiovascular risk in language that almost anyone can understand.
“As we get older, we get wrinkles in our skin, we get arthritis in our joints, we get plaques in our vessels,” Schuetze said. It is a useful analogy because it makes the invisible visible. Just as skin and joints show wear with age, blood vessels do too. Plaque buildup is part of that wear-and-tear process, but when too much accumulates, it can destabilize and lead to heart attacks or strokes.
That is why statins remain so central, even in an era obsessed with novelty. They lower LDL cholesterol and help make plaques less inflamed and more stable. In other words, they do not just lower a number on a lab report; they help make the plumbing safer.
Schuetze compared statins to sunscreen – a simple, preventive layer of protection applied broadly because it reduces risk, even if you cannot predict exactly who will have a major event.
It is an elegant analogy, and a subtle rebuke to the idea that newer always means better. Longevity is not just about finding exotic interventions; often it is about scaling the boring ones that already work.
“Tests tell us what we can do, but patients tell us what we should do,” Schuetze said. That best captures the modern longevity dilemma. Data can illuminate risk, but it cannot decide values. Some patients want every possible insight. Others want only what will clearly change care. Good prevention, then, is also relational.
Concierge medicine as a bridge, not the endpoint
Vail Health’s concierge medicine program adds another layer to the story, and perhaps the most commercially relevant one.
The program offers patients more access to physicians, additional testing and even possible home visits, features that are increasingly attractive in a US primary care environment strained by physician shortages and post-pandemic access bottlenecks.
That makes concierge medicine easy to dismiss as a premium product for the worried well. However, Vail Health seems to be positioning it more as a testing ground for what preventive care could become.
“It’s trying to tailor the approach to the resources that we have and also the needs of the community and also leverage what technologies we have to serve the greatest number of people as efficiently as possible,” O’Meara said.
The program is not only about exclusivity. It is also about workflow, demand and the challenge of delivering more personalized care in a system that is stretched thin.
The field will not be judged only by how sophisticated its tools become. It will be judged by whether those tools become more useful, more understandable and more widely available without turning healthy people into permanent patients.
Vail Health’s real contribution here is not that it is offering access to the newest tests. It is that it is trying to reframe longevity as a discipline of discernment. Start with strength, sleep, purpose and routine care. Add technology when it meaningfully sharpens the picture. Resist the temptation to treat every innovation as a necessity.
Main photograph shows an event hosted by Vail Health at the Singletree Pavilion about how to make the most of primary care and recent health care advances in testing and medication. Credit: Zoe Goldstein/Vail Daily.
[1] https://www.vaildaily.com/news/vail-health-longevity-health-care-concierge-medicine/
